# The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study

> **NCT06059664** · PHASE2 · RECRUITING · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 100 (estimated)

## Conditions studied

- Kidney Transplant; Complications

## Interventions

- **DRUG:** Finerenone Oral Tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06059664
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-23
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-04-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06059664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06059664, "The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06059664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*